CytoSorbents Continues Strong Trajectory of Growth in the Third Quarter 2017
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
Cytosorbents (CTSO) Reports In-Line Q3 EPS
November 9, 2017 4:19 PM ESTCytosorbents (NASDAQ: CTSO) reported Q3 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $3.45 million versus the consensus estimate of $3.86 million.
For earnings history and earnings-related data on Cytosorbents (CTSO) click here.
... More